Why is ergosterol targeted by antifungals?

Why is ergosterol targeted by antifungals?

• A. It is a structural component of bacterial membranes
• B. It allows for selective toxicity that is not possible with cholesterol
• C. It is easily degraded in host cells
• D. It does not exist in human cells

Answer: (B)

Ergosterol is a key component of fungal cell membranes, analogous to cholesterol in human and animal cells. Its specific presence in fungi allows for selective toxicity in antifungal treatments, meaning that drugs targeting ergosterol can effectively disrupt the integrity of fungal membranes without harming human cells. This selective targeting is crucial for reducing side effects and enhancing the efficacy of antifungal therapy.

The other options do not accurately relate to why ergosterol is a target for antifungal medications. For example, its role as a structural component pertains more to the cell membrane of fungi rather than bacteria. Additionally, the claim about easy degradation in host cells doesn’t pertain to how antifungals operate or target ergosterol specifically. Lastly, while ergosterol is indeed absent in human cells, it's the unique nature of ergosterol as a target for drug development that underscores the rationale for selective toxicity rather than merely its absence from human cells.